![Roger Adsett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Adsett
Chief Operating Officer at
INSMED INCORPORATED
Net worth: 11 M $ as of 2026-05-30
Profile
Roger Adsett is currently Director at Definium Therapeutics, Inc. since 2026 and Chief Operating Officer at Insmed, Inc. since 2019.
Former roles include Independent Director at Landos Biopharma, Inc. from 2022 to 2024, SVP, Head-Gastrointestinal & Internal Medicine at Shire Plc from 2015 to 2016, Director-Marketing & Brand at AstraZeneca PLC from 1994 to 2005, and Marketing Director positions at AstraZeneca R & D Lund and Nexium, Inc. Education includes an undergraduate degree from Bucknell University and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INSMED INCORPORATED 0.05% | 2026-06-02 | 98,603 ( 0.05% ) | 11 M $ | 2026-05-30 |
| 2026-01-28 | 0 ( -.--% ) | - $ | 2026-05-30 |
Roger Adsett active positions
| Companies | Position | Start |
|---|---|---|
| INSMED INCORPORATED | Chief Operating Officer | 2019-11-13 |
| DEFINIUM THERAPEUTICS, INC. | Director/Board Member | 2026-01-28 |
Former positions of Roger Adsett
| Companies | Position | End |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Director/Board Member | 2024-05-22 |
| SHIRE | Corporate Officer/Principal | 2016-08-31 |
| ASTRAZENECA PLC | Sales & Marketing | 2005-09-30 |
Nexium, Inc.
 Nexium, Inc. Investment ManagersFinance Functions as a pension/retirement fund | Sales & Marketing | - |
AstraZeneca R & D Lund | Sales & Marketing | - |
Training of Roger Adsett
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca R & D Lund | |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexium, Inc.
Nexium, Inc. Investment ManagersFinance Functions as a pension/retirement fund | Finance |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Mind Medicine (MindMed), Inc.
 Mind Medicine (MindMed), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical biopharmaceutical company which develops novel products to treat brain health disorders | Health Technology |
- Stock Market
- Insiders
- Roger Adsett
